Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
23.86
+0.73 (3.16%)
Dec 20, 2024, 4:00 PM EST - Market closed
Spyre Therapeutics Employees
Spyre Therapeutics had 30 employees as of December 31, 2023. The number of employees decreased by 39 or -56.52% compared to the previous year.
Employees
30
Change (1Y)
-39
Growth (1Y)
-56.52%
Revenue / Employee
n/a
Profits / Employee
-$7,163,400
Market Cap
1.40B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
U.S. Physical Therapy | 6,720 |
Novavax | 1,543 |
Schrödinger | 867 |
Maravai LifeSciences Holdings | 650 |
Arcus Biosciences | 577 |
Immunocore Holdings | 497 |
RxSight | 374 |
Nurix Therapeutics | 284 |
SYRE News
- 3 days ago - Spyre Therapeutics Added to the Nasdaq Biotechnology Index - PRNewsWire
- 17 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Spyre Therapeutics, Inc. (SYRE) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 18 days ago - Spyre Therapeutics, Inc. (SYRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 19 days ago - Spyre Therapeutics Announces Grants of Inducement Awards - PRNewsWire
- 19 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Spyre Therapeutics, Inc. (SYRE) Shareholders to Inquire about Securities Investigation - Accesswire
- 19 days ago - Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life Extended Anti-TL1A Antibodies - PRNewsWire
- 20 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Spyre Therapeutics, Inc. (SYRE) And Encourages Shareholders to Connect - Accesswire
- 22 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Spyre Therapeutics, Inc. (SYRE) Stockholders to Inquire about Securities Investigation - Accesswire